Wolverine Trading, LLC Pacira Bio Sciences, Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $119,340 - $290,292	10,200 New	10,200 $153,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $678,623 - $828,558	19,100 New	19,100 $767,000
Q4 2019 Feb 12, 2020	SELL	$36.31 - $46.83 $206,967 - $266,931	-5,700 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $178,299 - $224,950	-5,000 Reduced 46.73%	5,700 $228,000
Q2 2019 Aug 20, 2019	SELL	$36.57 - $47.97 $142,623 - $187,083	-3,900 Reduced 26.71%	10,700 $465,000
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $76,587 - $88,557	2,100 Added 16.8%	14,600 $556,000
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $516,375 - $652,000	12,500 New	12,500 $531,000
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $471,380 - $694,860	-14,800 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$35.7 - $39.5 $528,360 - $584,600	14,800	14,800 $556,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.